|
KMID : 1037120210390020352
|
|
The World Journal of Men′s Health
2021 Volume.39 No. 2 p.352 ~ p.357
|
|
|
Comparison of Intralesional Hyaluronic Acid vs. Verapamil for the Treatment of Acute Phase Peyronie's Disease: A Prospective, Open-Label Non-Randomized Clinical Study
|
|
Cocci Andrea
Di Maida Fabrizio
Cito Gianmartin
Verrienti Pierangelo
Laruccia Nicola
Campi Riccardo
Mari Andrea
di Mauro Marina
Falcone Marco
Cacciamani Giovanni E.
Garaffa Giulio
Minervini Andrea
Russo Giorgio Ivan
|
|
|
Abstract
|
|
|
Purpose: To compare the efficacy and safety of intralesional hyaluronic acid (HA) as compared with verapamil injection in patients with Peyronie's disease (PD).
Materials and Methods: Between January 2015 and December 2018, men in PD acute phase were prospectively recruited. This open-label, prospective study included 2 different protocols. Group A: 8-week cycle of weekly intraplaque injections with HA; Group B: 8-week cycle of weekly intraplaque injections with verapamil. Penile curvature, plaque size, International Index of Erectile Function (IIEF)-15 score and visual analogue scale (VAS) were assessed at baseline and after 3 months.
Results: Two-hundred forty-four patients were enrolled. Of these, 125 received intralesional HA (Group A), 119 received intralesional verapamil (Group B). At enrollment, median age was 56.0 years (interquartile range [IQR]=47.0?63.0 years), median curvature 35.0° (IQR=25.0°?45.0°), median IIEF-15 score 19.0 (IQR=16.0?23.0), median VAS 4.0 (IQR=4.0?5.0). Median difference for IIEF-15 was 1.0 (95% confidence interval [CI]=1.12?1.94) in Group A and 0.0 (95% CI=?0.04?0.14) in Group B (p<0.05) and median difference for VAS score was ?4.0 (95% CI=?4.11??3.65) in Group A and ?1.0 (95% CI=?0.50?2.01) in Group B (p<0.05). Plaque size decreased by ?1.50 mm (IQR=1.60?2.10 mm) in Group A and ?1.20 in Group B (p=0.10), while penile curvature decreased by ?9.50° (IQR=4.50°?13.00°) in group A and ?4.50 (IQR=2.50?7.50) in Group B (p<0.01).
Conclusions: Intralesional HA injections could represent a reliable treatment option for the conservative management of patients with acute phase of PD.
|
|
|
KEYWORD
|
|
|
Hyaluronic acid, Penile curvature, Penile induration, Peyronie disease, Verapamil
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
   
|
|